Philip Moriarty discusses Molecular Nanotechnology Validation experiment plans

by

On the Center for Responsible Nanotechnology blog comments, Philip Moriarty discusses his plans for testing the viability of positionally-controlled atom-by-atom fabrication of diamondoid materials as described in the Freitas-Merkle minimal toolset theory paper. A combination of low temperature tuning fork (Qplus) AFM, STM, and tunnelling spectroscopy (dI/dV and d2I/dV2, i.e. inelastic tunnelling spectroscopy) will be …

Read more

Philip Moriarty discusses Molecular Nanotechnology Validation experiment plans

by

On the Center for Responsible Nanotechnology blog comments, Philip Moriarty discusses his plans for testing the viability of positionally-controlled atom-by-atom fabrication of diamondoid materials as described in the Freitas-Merkle minimal toolset theory paper. A combination of low temperature tuning fork (Qplus) AFM, STM, and tunnelling spectroscopy (dI/dV and d2I/dV2, i.e. inelastic tunnelling spectroscopy) will be …

Read more

Stem cells for Unlimited Blood Supply Could Provide the money for Stem Cell Life Extension

by

Advanced Cell Technology is the company behind the new stem cell blood breakthrough which could supply unlimited disease free blood. The company is only up 50% to a valuation of 6.7 million. Biotime is a related company Robert Lanza is the chief scientist behind Advanced Cell Technology and was featured in Discover Magazine. He is …

Read more

Stem cells for Unlimited Blood Supply Could Provide the money for Stem Cell Life Extension

by

Advanced Cell Technology is the company behind the new stem cell blood breakthrough which could supply unlimited disease free blood. The company is only up 50% to a valuation of 6.7 million. Biotime is a related company Robert Lanza is the chief scientist behind Advanced Cell Technology and was featured in Discover Magazine. He is …

Read more

Aubrey de Grey Interview at betterhumans

by

Aubrey de Grey interview on longevity, life extension and Strategies for Engineered Negligible Senescence (SENS) at betterhumans.com Estimate of the timing of results: I [Aubrey] think there’s a 50% chance of getting the first-generation SENS therapies working within 25-30 years. But that’s only an estimate, and it’s a highly speculative one: I think there’s at …

Read more

Aubrey de Grey Interview at betterhumans

by

Aubrey de Grey interview on longevity, life extension and Strategies for Engineered Negligible Senescence (SENS) at betterhumans.com Estimate of the timing of results: I [Aubrey] think there’s a 50% chance of getting the first-generation SENS therapies working within 25-30 years. But that’s only an estimate, and it’s a highly speculative one: I think there’s at …

Read more

French process to extract uranium from reactor ash

by

Areva and the University of Idaho have signed an agreement to develop technology for recovering uranium from incinerator ash at Areva’s uranium fuel plant in Richland, Washington state. The process also reduces the amount of ash classified as radioactive waste. Chien Wai, a chemistry professor at the University of Idaho, has developed a process that …

Read more

French process to extract uranium from reactor ash

by

Areva and the University of Idaho have signed an agreement to develop technology for recovering uranium from incinerator ash at Areva’s uranium fuel plant in Richland, Washington state. The process also reduces the amount of ash classified as radioactive waste. Chien Wai, a chemistry professor at the University of Idaho, has developed a process that …

Read more

Stem cell blood supply breakthrough and other stem cell breakthroughs

by

Human blood have been grown from embryonic stem cells for the first time during research that promises to provide an almost limitless supply suitable for transfusion into any patient. This could lead to trials of the blood within two years, and ultimately to an alternative to donations that would transform medicine. If such blood was …

Read more